Emergent BioSolutions (EBS) Intangibles (2013 - 2026)
Emergent BioSolutions (EBS) posted Intangibles of $261.8 million for Q2 2026, down 44.35% on a QoQ basis from $470.4 million in Q1 2026, and down 44.18% year-over-year from $469.0 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Intangibles (2013 - 2026) Analysis & Trends
Emergent BioSolutions has reported Intangibles for 14 years, with the latest figure at $261.8 million in Q2 2026.
- On a quarterly basis, Intangibles fell 44.18% year-over-year to $261.8 million in Q2 2026; TTM through Jun 2026 was $261.8 million, a 44.18% decrease from a year earlier, with the FY2025 full-year figure at $436.5 million, down 12.96% from the prior year.
- Intangibles was $261.8 million for Q2 2026 at Emergent BioSolutions, down from $470.4 million in the prior quarter.
- The five-year high for Intangibles was $728.8 million in Q4 2022, with the low at $261.8 million in Q2 2026.
- Average Intangibles over 5 years is $536.2 million, with a median of $542.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Intangibles climbed 20.54% in 2022, then plunged 44.18% in 2026.
- Over 5 years, Intangibles stood at $728.8 million in 2022, then decreased by 22.26% to $566.6 million in 2023, then fell by 11.49% to $501.5 million in 2024, then retreated by 12.96% to $436.5 million in 2025, then sank by 40.02% to $261.8 million in 2026.
- The last three Intangibles figures came in at $261.8 million (Q2 2026), $470.4 million (Q1 2026), and $436.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 17.39 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 30.64 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 60.96 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 63.28 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 261.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.80 Mn |
| Mar 31, 2026 | 470.40 Mn |
| Dec 31, 2025 | 436.50 Mn |
| Sep 30, 2025 | 452.70 Mn |
| Jun 30, 2025 | 469.00 Mn |
| Mar 31, 2025 | 485.20 Mn |
| Dec 31, 2024 | 501.50 Mn |
| Sep 30, 2024 | 517.80 Mn |
| Jun 30, 2024 | 534.10 Mn |
| Mar 31, 2024 | 550.40 Mn |
| Dec 31, 2023 | 566.60 Mn |
| Sep 30, 2023 | 582.80 Mn |
| Jun 30, 2023 | 592.80 Mn |
| Mar 31, 2023 | 608.90 Mn |
| Dec 31, 2022 | 728.80 Mn |
| Sep 30, 2022 | 724.90 Mn |
| Jun 30, 2022 | 576.60 Mn |
| Mar 31, 2022 | 590.60 Mn |
| Dec 31, 2021 | 604.60 Mn |
| Sep 30, 2021 | 618.60 Mn |
API Access
Emergent BioSolutions Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();